Literature DB >> 3459916

Employment of a [3H]thymidine-incorporation assay to distinguish the effects of different Friend erythroleukemia-inducing retroviruses on erythroid cell proliferation.

S K Ruscetti.   

Abstract

Spleen cells taken from mice infected as adults with two different variants of the spleen focus-forming virus (SFFV), SFFVP and SFFVA, as well as spleen cells taken from mice infected as newborns with Friend murine leukemia virus (F-MuLV) were assayed in a proliferation assay in the presence or absence of the erythroid hormone erythropoietin (Epo). Infection of NIH Swiss mice with SFFV resulted in excessive proliferation of erythroid cells that could still differentiate, and spleen cells taken from these mice were able to incorporate high levels of tritiated thymidine ([3H]dThd) in the absence of Epo, even in the presence of antibodies to Epo. In contrast, the level of proliferation of spleen cells from SFFVA-infected mice, but not those from SFFVP-infected mice, could be greatly enhanced by the addition of Epo to the cultures. Infection of newborn mice with F-MuLV resulted in the generation of Friend mink cell focus-inducing virus, which caused excessive proliferation of erythroid cells that appeared to be blocked in differentiation, resulting in severe anemia. Spleen cells from these mice were unable to proliferate in the absence of Epo. However, when increasing doses of Epo were added to the cultures, the cells proliferated at levels equivalent to the levels seen with SFFV. These results indicate that a proliferation assay based on the incorporation of [3H]dThd into spleen cells in response to Epo can be used as a quantitative means of assessing and comparing the effects of erythroleukemia-inducing retroviruses on the proliferation of their target cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3459916

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

1.  Both the polycythemia- and anemia-inducing strains of Friend spleen focus-forming virus induce constitutive activation of the Raf-1/mitogen-activated protein kinase signal transduction pathway.

Authors:  K W Muszynski; T Ohashi; C Hanson; S K Ruscetti
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

2.  Transmembrane domain of the envelope gene of a polycythemia-inducing retrovirus determines erythropoietin-independent growth.

Authors:  S W Chung; L Wolff; S K Ruscetti
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Sequences responsible for the altered erythropoietin responsiveness in spleen focus-forming virus strain SFFVP-infected cells are localized to a 678-base-pair region at the 3' end of the envelope gene.

Authors:  S W Chung; L Wolff; S Ruscetti
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

4.  Friend spleen focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line.

Authors:  S K Ruscetti; N J Janesch; A Chakraborti; S T Sawyer; W D Hankins
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

5.  A Friend virus mutant that overcomes Fv-2rr host resistance encodes a small glycoprotein that dimerizes, is processed to cell surfaces, and specifically activates erythropoietin receptors.

Authors:  S L Kozak; M E Hoatlin; F E Ferro; M K Majumdar; R W Geib; M T Fox; D Kabat
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

6.  Induction of erythropoietin responsiveness in murine hematopoietic cells by the gag-myb-ets-containing ME26 virus.

Authors:  S Ruscetti; R Aurigemma; C C Yuan; S Sawyer; D G Blair
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

7.  The spleen focus-forming virus (SFFV) envelope gene, when introduced into mice in the absence of other SFFV genes, induces acute erythroleukemia.

Authors:  L Wolff; S Ruscetti
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

8.  Transforming growth factor beta 1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3-dependent myeloid leukemia cell lines.

Authors:  J R Keller; C Mantel; G K Sing; L R Ellingsworth; S K Ruscetti; F W Ruscetti
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.